臨床化学分析装置の世界市場規模調査＆予測：製品タイプ別、検査タイプ別、エンドユーザー別、地域別分析、2023-2030年

臨床化学分析装置の世界市場は、2022年に約131億5,000万米ドルと評価され、予測期間2023-2030年には4.28%以上の健全な成長率で成長すると予測されています。

臨床化学分析装置は、血液、血清、血漿、尿、その他の体液などの生体試料中の様々な化学成分を分析するために使用される医療検査機器です。この種の分析装置は臨床化学において不可欠なツールです。臨床化学は臨床病理学の一分野であり、体液の化学組成を研究して病気の診断、治療、モニタリングに役立てることに主眼を置いています。臨床化学分析装置市場は、高齢者人口の増加や慢性疾患の蔓延といった要因によって拡大しています。

臨床化学分析装置は、血液、血漿、尿、脳脊髄液などの検体を分析し、疾患や薬剤に関連する分析物の存在を検出します。世界の人口は、特に先進国では高齢化が進んでいます。高齢化に伴い、慢性疾患への罹患率が高くなり、これらの疾患を効果的に監視・管理するための臨床化学分析装置のような診断ツールの必要性が高まっています。2021年10月に発表されたWHOの高齢化と健康に関する文書によると、2030年までに約6人に1人が60歳以上の高齢者になります。同じ研究では、2020年の10億人から2030年には14億人が60歳を超えると予測しています。さらに、臨床化学分析装置は、血液、血清、血漿、脳脊髄液など複数の成分の脂質、電解質、血漿グルコース値、その他のプロファイルを分析することにより、このような慢性疾患の評価において重要な役割を果たしています。その結果、慢性疾患の有病率が増加し、市場が成長すると予測されています。GLOBOCAN 2020報告書では、2020年に世界で新たにがんに罹患した患者数はおよそ1,929万2,789人と推定されています。2040年には、28,887,940人になると予測されています。さらに、IDF Diabetes Atlas Tenth Edition 2021によると、2021年には世界で約5億3,700万人の成人が糖尿病であることが判明しており、この数字は2030年までに6億4,300万人、2045年までに7億8,300万人に増加すると推定されています。さらに、ポイント・オブ・ケア検査に対する需要の高まりや臨床化学分析装置の技術的進歩の高まりは、市場に有利な機会を生み出す要因のひとつです。しかし、臨床化学分析装置のコストが高く、訓練を受けた有資格の専門家が不足していることが、2023～2030年の予測期間を通じて市場の成長を阻害しています。

臨床化学分析装置の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は2022年に市場を席巻したが、これは疾患有病率の上昇、主な市場プレイヤーの存在、ヘルスケア支出の増加、臨床開拓のための投資の増加、同地域における有利な政府イニシアチブの台頭などの要因によるものです。一方、アジア太平洋地域は、老人人口の増加、慢性疾患の有病率の上昇、医療投資の増加などの要因により、大きな成長を記録すると予測されています。

本調査の目的は、近年における様々なセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。.

目次

第1章 エグゼクティブサマリー

第2章 臨床化学分析装置の世界市場の定義と範囲

• 調査目的
• 市場の定義と範囲
  • 業界の進化
  • 調査範囲
• 調査対象年
• 通貨換算レート

第3章 臨床化学分析装置の世界市場力学

• 臨床化学分析装置市場の影響分析（2020-2030年）
  • 市場促進要因
    • 高齢者人口の増加
    • 慢性疾患の増加
  • 市場の課題
    • 臨床化学分析装置の高コスト
    • 訓練を受けた有資格の専門家の不足
  • 市場機会
    • ポイントオブケア検査への需要の高まり
    • 臨床化学分析装置における技術進歩の高まり

第4章 臨床化学分析装置の世界市場産業分析

• ポーターの5フォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターの5フォース影響分析
• PEST分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 環境
  • 法律
• 主な投資機会
• 主要成功戦略
• COVID-19影響分析
• 破壊的動向
• 業界専門家の視点
• アナリストの提言・結論

第5章 臨床化学分析装置の世界市場：製品別

• 市場スナップショット
• 臨床化学分析装置の世界市場：製品別、実績 - ポテンシャル分析
• 臨床化学分析装置の世界市場：製品別推定・予測2020～2030年
• 臨床化学分析装置市場、サブセグメント分析
  • 分析装置
  • 試薬
  • その他

第6章 臨床化学分析装置の世界市場：検査タイプ別

• 市場スナップショット
• 臨床化学分析装置の世界市場：検査タイプ別、実績 - ポテンシャル分析
• 臨床化学分析装置の世界市場：検査タイプ別推定・予測2020-2030年
• 臨床化学分析装置市場、サブセグメント分析
  • 肝臓パネル
  • 電解質パネル
  • 甲状腺機能パネル
  • 脂質プロファイル
  • その他

第7章 臨床化学分析装置の世界市場：エンドユーザー別

• 市場スナップショット
• 臨床化学分析装置の世界市場：エンドユーザー別、実績 - ポテンシャル分析
• 臨床化学分析装置の世界市場：エンドユーザー別推定・予測2020～2030年
• 臨床化学分析装置市場、サブセグメント分析
  • 病院
  • 診断研究所
  • 学術機関
  • その他

第8章 臨床化学分析装置の世界市場：地域別分析

• 主要国
• 主な新興国
• 臨床化学分析装置市場、地域別市場スナップショット
• 北米
  • 米国
    • 製品の推定・予測、2020-2030年
    • 検査タイプの推定・予測、2020～2030年
    • エンドユーザーの推定・予測、2020～2030年
  • カナダ
• 欧州臨床化学分析装置市場スナップショット
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• アジア太平洋臨床化学分析装置市場スナップショット
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカの臨床化学分析装置市場スナップショット
  • ブラジル
  • メキシコ
• 中東・アフリカ
  • サウジアラビア
  • 南アフリカ
  • その他中東とアフリカ

第9章 競合情報

• 主要企業のSWOT分析
• 主要市場戦略
• 企業プロファイル
  • Abbott Laboratories
    • 主要情報
    • 概要
    • 財務（データの入手可能性によります）
    • 製品概要
    • 最近の動向
  • Danaher Corporation（Beckman Coulter, Inc.）
  • Elitech Group
  • F. Hoffmann-La Roche AG
  • Horiba, Ltd.
  • Johnson & Johnson Pvt Ltd.
  • Mindray Medical International Limited
  • Siemens Healthcare Private Limited
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.

第10章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • 検証
  • 出版
• 調査属性
• 調査前提条件

LIST OF TABLES

• TABLE 1. Global Clinical Chemistry Analyzer Market, report scope
• TABLE 2. Global Clinical Chemistry Analyzer Market estimates & forecasts by Region 2020-2030 (USD Billion)
• TABLE 3. Global Clinical Chemistry Analyzer Market estimates & forecasts by Product 2020-2030 (USD Billion)
• TABLE 4. Global Clinical Chemistry Analyzer Market estimates & forecasts by Types of Test 2020-2030 (USD Billion)
• TABLE 5. Global Clinical Chemistry Analyzer Market estimates & forecasts by End User 2020-2030 (USD Billion)
• TABLE 6. Global Clinical Chemistry Analyzer Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 7. Global Clinical Chemistry Analyzer Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 8. Global Clinical Chemistry Analyzer Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 9. Global Clinical Chemistry Analyzer Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 10. Global Clinical Chemistry Analyzer Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 11. Global Clinical Chemistry Analyzer Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 12. Global Clinical Chemistry Analyzer Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 13. Global Clinical Chemistry Analyzer Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 14. Global Clinical Chemistry Analyzer Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 15. Global Clinical Chemistry Analyzer Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 16. U.S. Clinical Chemistry Analyzer Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 17. U.S. Clinical Chemistry Analyzer Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 18. U.S. Clinical Chemistry Analyzer Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 19. Canada Clinical Chemistry Analyzer Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 20. Canada Clinical Chemistry Analyzer Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 21. Canada Clinical Chemistry Analyzer Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 22. UK Clinical Chemistry Analyzer Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 23. UK Clinical Chemistry Analyzer Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 24. UK Clinical Chemistry Analyzer Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 25. Germany Clinical Chemistry Analyzer Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 26. Germany Clinical Chemistry Analyzer Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 27. Germany Clinical Chemistry Analyzer Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 28. France Clinical Chemistry Analyzer Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 29. France Clinical Chemistry Analyzer Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 30. France Clinical Chemistry Analyzer Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 31. Italy Clinical Chemistry Analyzer Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 32. Italy Clinical Chemistry Analyzer Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 33. Italy Clinical Chemistry Analyzer Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 34. Spain Clinical Chemistry Analyzer Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 35. Spain Clinical Chemistry Analyzer Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 36. Spain Clinical Chemistry Analyzer Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 37. RoE Clinical Chemistry Analyzer Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 38. RoE Clinical Chemistry Analyzer Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 39. RoE Clinical Chemistry Analyzer Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 40. China Clinical Chemistry Analyzer Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 41. China Clinical Chemistry Analyzer Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 42. China Clinical Chemistry Analyzer Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 43. India Clinical Chemistry Analyzer Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 44. India Clinical Chemistry Analyzer Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 45. India Clinical Chemistry Analyzer Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 46. Japan Clinical Chemistry Analyzer Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 47. Japan Clinical Chemistry Analyzer Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 48. Japan Clinical Chemistry Analyzer Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 49. South Korea Clinical Chemistry Analyzer Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 50. South Korea Clinical Chemistry Analyzer Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 51. South Korea Clinical Chemistry Analyzer Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 52. Australia Clinical Chemistry Analyzer Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 53. Australia Clinical Chemistry Analyzer Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 54. Australia Clinical Chemistry Analyzer Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 55. RoAPAC Clinical Chemistry Analyzer Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 56. RoAPAC Clinical Chemistry Analyzer Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 57. RoAPAC Clinical Chemistry Analyzer Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 58. Brazil Clinical Chemistry Analyzer Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 59. Brazil Clinical Chemistry Analyzer Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 60. Brazil Clinical Chemistry Analyzer Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 61. Mexico Clinical Chemistry Analyzer Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 62. Mexico Clinical Chemistry Analyzer Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 63. Mexico Clinical Chemistry Analyzer Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 64. RoLA Clinical Chemistry Analyzer Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 65. RoLA Clinical Chemistry Analyzer Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 66. RoLA Clinical Chemistry Analyzer Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 67. Saudi Arabia Clinical Chemistry Analyzer Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 68. South Africa Clinical Chemistry Analyzer Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 69. RoMEA Clinical Chemistry Analyzer Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 70. List of secondary sources, used in the study of global Clinical Chemistry Analyzer Market
• TABLE 71. List of primary sources, used in the study of global Clinical Chemistry Analyzer Market
• TABLE 72. Years considered for the study
• TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

• FIG 1. Global Clinical Chemistry Analyzer Market, research methodology
• FIG 2. Global Clinical Chemistry Analyzer Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Clinical Chemistry Analyzer Market, key trends 2022
• FIG 5. Global Clinical Chemistry Analyzer Market, growth prospects 2023-2030
• FIG 6. Global Clinical Chemistry Analyzer Market, porters 5 force model
• FIG 7. Global Clinical Chemistry Analyzer Market, pest analysis
• FIG 8. Global Clinical Chemistry Analyzer Market, value chain analysis
• FIG 9. Global Clinical Chemistry Analyzer Market by segment, 2020 & 2030 (USD Billion)
• FIG 10. Global Clinical Chemistry Analyzer Market by segment, 2020 & 2030 (USD Billion)
• FIG 11. Global Clinical Chemistry Analyzer Market by segment, 2020 & 2030 (USD Billion)
• FIG 12. Global Clinical Chemistry Analyzer Market by segment, 2020 & 2030 (USD Billion)
• FIG 13. Global Clinical Chemistry Analyzer Market by segment, 2020 & 2030 (USD Billion)
• FIG 14. Global Clinical Chemistry Analyzer Market, regional snapshot 2020 & 2030
• FIG 15. North America Clinical Chemistry Analyzer Market 2020 & 2030 (USD Billion)
• FIG 16. Europe Clinical Chemistry Analyzer Market 2020 & 2030 (USD Billion)
• FIG 17. Asia pacific Clinical Chemistry Analyzer Market 2020 & 2030 (USD Billion)
• FIG 18. Latin America Clinical Chemistry Analyzer Market 2020 & 2030 (USD Billion)
• FIG 19. Middle East & Africa Clinical Chemistry Analyzer Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Clinical Chemistry Analyzer Market is valued at approximately USD 13.15 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 4.28% over the forecast period 2023-2030. A Clinical Chemistry Analyzer is a medical laboratory instrument used to analyze various chemical components in biological samples such as blood, serum, plasma, urine, and other bodily fluids. This type of analyzer is an essential tool in clinical chemistry, which is a branch of clinical pathology focused on studying the chemical composition of bodily fluids to aid in the diagnosis, treatment, and monitoring of diseases. The Clinical Chemistry Analyzer market is expanding because of factors such as rising geriatric population and increasing prevalence of chronic diseases.

The clinical chemistry analyzers conduct assays on samples such as blood, plasma, urine, and cerebrospinal fluid to find the presence of analytes linked to disease or medications. The global population is aging, particularly in developed countries. With aging, there is a higher susceptibility to chronic illnesses and a greater need for diagnostic tools such as clinical chemistry analyzers to monitor and manage these conditions effectively. According to a WHO document on ageing and health that was released in October 2021, around 1 in 6 people would be older than 60 by the year 2030. The same study predicts that 1.4 billion people, up from 1 billion in 2020, would be beyond the age of 60 by 2030. In addition, Clinical chemistry analyzers play a critical role in the evaluation of such chronic disorders by analyzing the lipids, electrolytes, plasma glucose levels, and other profiles of several components including blood, serum, plasma, and cerebrospinal fluid, among others. In turn, it is projected that the prevalence of chronic illnesses would increase, resulting in market growth. The GLOBOCAN 2020 report estimates that there were roughly 19,292,789 new cases of cancer worldwide in 2020. By 2040, there would likely be 28,887,940 instances, according to projections. Additionally, according to the IDF Diabetes Atlas Tenth Edition 2021, about 537 million adults worldwide were discovered to have diabetes in 2021, with estimates showing that figure wouldrise to 643 million by 2030 and 783 million by 2045. In addition, growing demand for point-of-care testing and rising technological advancements in clinical chemistry analyzers are some factors creating lucrative opportunities for the market. However, the high cost of clinical chemistry analyzers, the lack of trained and qualified professional's stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Clinical Chemistry Analyzer Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to factors such as rising disease prevalence, presence of key market players, increasing healthcare expenditure, rising investment for clinical development, and rising favorable government initiatives in the region. Whereas, Asia Pacific is projected to register significant growth owing to factors such as a rising geriatric population, rising prevalence of chronic diseases, and rising healthcare investments in the region.

Major market player included in this report are:

• Abbott Laboratories
• Danaher Corporation (Beckman Coulter, Inc.)
• Elitech Group
• F. Hoffmann-La Roche AG
• Horiba, Ltd.
• Johnson & Johnson Pvt Ltd
• Mindray Medical International Limited
• Siemens Healthcare Private Limited
• Sysmex Corporation
• Thermo Fisher Scientific Inc.

Recent Developments in the Market:

• In May 2022, Mindray unveiled the BS-600M, a powerful, efficient chemistry analyzer, to increase productivity, efficiency, and dependability in medium-volume laboratories.
• In April 2022, Sysmex Europe unveiled the XQ-320 XQ-Series Automated Haematology Analyzer as a brand-new three-part differential system. The XQ-320 uses trustworthy technology and a new level of use to give outstanding quality in a range of clinical laboratory applications.

Global Clinical Chemistry Analyzer Market Report Scope:

• Historical Data: 2020 - 2021
• Base Year for Estimation: 2022
• Forecast period: 2023-2030
• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered: Product, Types of Test, End user, Region
• Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Product:

• Analyzers
• Reagents
• Others

By Types of Type:

• Liver Panels
• Electrolyte Panels
• Thyroid Function Panels
• Lipid Profiles
• Others

By End User:

• Hospital
• Diagnostic Laboratories
• Academic Institutes
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1. Clinical Chemistry Analyzer Market, by Region, 2020-2030 (USD Billion)
  • 1.2.2. Clinical Chemistry Analyzer Market, by Product, 2020-2030 (USD Billion)
  • 1.2.3. Clinical Chemistry Analyzer Market, by Types of Tests, 2020-2030 (USD Billion)
  • 1.2.4. Clinical Chemistry Analyzer Market, by End User, 2020-2030 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Clinical Chemistry Analyzer Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Clinical Chemistry Analyzer Market Dynamics

• 3.1. Clinical Chemistry Analyzer Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Growing geriatric population
    • 3.1.1.2. Increasing prevalence of chronic diseases
  • 3.1.2. Market Challenges
    • 3.1.2.1. High Cost of Clinical Chemistry Analyzer
    • 3.1.2.2. Lack of trained and qualified professionals
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Growing demand for point-of-care testing
    • 3.1.3.2. Rising technological advancements in clinical chemistry analyzer

Chapter 4. Global Clinical Chemistry Analyzer Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Clinical Chemistry Analyzer Market, by Product

• 5.1. Market Snapshot
• 5.2. Global Clinical Chemistry Analyzer Market by Product, Performance - Potential Analysis
• 5.3. Global Clinical Chemistry Analyzer Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
• 5.4. Clinical Chemistry Analyzer Market, Sub Segment Analysis
  • 5.4.1. Analyzers
  • 5.4.2. Reagents
  • 5.4.3. Others

Chapter 6. Global Clinical Chemistry Analyzer Market, by Types of Test

• 6.1. Market Snapshot
• 6.2. Global Clinical Chemistry Analyzer Market by Types of Test, Performance - Potential Analysis
• 6.3. Global Clinical Chemistry Analyzer Market Estimates & Forecasts by Types of Test 2020-2030 (USD Billion)
• 6.4. Clinical Chemistry Analyzer Market, Sub Segment Analysis
  • 6.4.1. Liver Panels
  • 6.4.2. Electrolyte Panels
  • 6.4.3. Thyroid Function Panels
  • 6.4.4. Lipid Profiles
  • 6.4.5. Others

Chapter 7. Global Clinical Chemistry Analyzer Market, by End User

• 7.1. Market Snapshot
• 7.2. Global Clinical Chemistry Analyzer Market by End User, Performance - Potential Analysis
• 7.3. Global Clinical Chemistry Analyzer Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
• 7.4. Clinical Chemistry Analyzer Market, Sub Segment Analysis
  • 7.4.1. Hospital
  • 7.4.2. Diagnostic Laboratories
  • 7.4.3. Academic Institutes
  • 7.4.4. Others

Chapter 8. Global Clinical Chemistry Analyzer Market, Regional Analysis

• 8.1. Top Leading Countries
• 8.2. Top Emerging Countries
• 8.3. Clinical Chemistry Analyzer Market, Regional Market Snapshot
• 8.4. North America Clinical Chemistry Analyzer Market
  • 8.4.1. U.S. Clinical Chemistry Analyzer Market
    • 8.4.1.1. Product breakdown estimates & forecasts, 2020-2030
    • 8.4.1.2. Types of Test breakdown estimates & forecasts, 2020-2030
    • 8.4.1.3. End User breakdown estimates & forecasts, 2020-2030
  • 8.4.2. Canada Clinical Chemistry Analyzer Market
• 8.5. Europe Clinical Chemistry Analyzer Market Snapshot
  • 8.5.1. U.K. Clinical Chemistry Analyzer Market
  • 8.5.2. Germany Clinical Chemistry Analyzer Market
  • 8.5.3. France Clinical Chemistry Analyzer Market
  • 8.5.4. Spain Clinical Chemistry Analyzer Market
  • 8.5.5. Italy Clinical Chemistry Analyzer Market
  • 8.5.6. Rest of Europe Clinical Chemistry Analyzer Market
• 8.6. Asia-Pacific Clinical Chemistry Analyzer Market Snapshot
  • 8.6.1. China Clinical Chemistry Analyzer Market
  • 8.6.2. India Clinical Chemistry Analyzer Market
  • 8.6.3. Japan Clinical Chemistry Analyzer Market
  • 8.6.4. Australia Clinical Chemistry Analyzer Market
  • 8.6.5. South Korea Clinical Chemistry Analyzer Market
  • 8.6.6. Rest of Asia Pacific Clinical Chemistry Analyzer Market
• 8.7. Latin America Clinical Chemistry Analyzer Market Snapshot
  • 8.7.1. Brazil Clinical Chemistry Analyzer Market
  • 8.7.2. Mexico Clinical Chemistry Analyzer Market
• 8.8. Middle East & Africa Clinical Chemistry Analyzer Market
  • 8.8.1. Saudi Arabia Clinical Chemistry Analyzer Market
  • 8.8.2. South Africa Clinical Chemistry Analyzer Market
  • 8.8.3. Rest of Middle East & Africa Clinical Chemistry Analyzer Market

Chapter 9. Competitive Intelligence

• 9.1. Key Company SWOT Analysis
  • 9.1.1. Company 1
  • 9.1.2. Company 2
  • 9.1.3. Company 3
• 9.2. Top Market Strategies
• 9.3. Company Profiles
  • 9.3.1. Abbott Laboratories
    • 9.3.1.1. Key Information
    • 9.3.1.2. Overview
    • 9.3.1.3. Financial (Subject to Data Availability)
    • 9.3.1.4. Product Summary
    • 9.3.1.5. Recent Developments
  • 9.3.2. Danaher Corporation (Beckman Coulter, Inc.)
  • 9.3.3. Elitech Group
  • 9.3.4. F. Hoffmann-La Roche AG
  • 9.3.5. Horiba, Ltd.
  • 9.3.6. Johnson & Johnson Pvt Ltd.
  • 9.3.7. Mindray Medical International Limited
  • 9.3.8. Siemens Healthcare Private Limited
  • 9.3.9. Sysmex Corporation
  • 9.3.10. Thermo Fisher Scientific Inc.

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption